Cancers (Feb 2022)

Microtentacle Formation in Ovarian Carcinoma

  • Jocelyn C. Reader,
  • Cong Fan,
  • Eleanor Claire-Higgins Ory,
  • Julia Ju,
  • Rachel Lee,
  • Michele I. Vitolo,
  • Paige Smith,
  • Sulan Wu,
  • Mc Millan Nicol Ching,
  • Emmanuel B. Asiedu,
  • Christopher M. Jewell,
  • Gautam G. Rao,
  • Amy Fulton,
  • Tonya J. Webb,
  • Peixin Yang,
  • Alessandro D. Santin,
  • Huang-Chiao Huang,
  • Stuart S. Martin,
  • Dana M. Roque

DOI
https://doi.org/10.3390/cancers14030800
Journal volume & issue
Vol. 14, no. 3
p. 800

Abstract

Read online

Background: The development of chemoresistance to paclitaxel and carboplatin represents a major therapeutic challenge in ovarian cancer, a disease frequently characterized by malignant ascites and extrapelvic metastasis. Microtentacles (McTNs) are tubulin-based projections observed in detached breast cancer cells. In this study, we investigated whether ovarian cancers exhibit McTNs and characterized McTN biology. Methods: We used an established lipid-tethering mechanism to suspend and image individual cancer cells. We queried a panel of immortalized serous (OSC) and clear cell (OCCC) cell lines as well as freshly procured ascites and human ovarian surface epithelium (HOSE). We assessed by Western blot β-tubulin isotype, α-tubulin post-translational modifications and actin regulatory proteins in attached/detached states. We studied clustering in suspended conditions. Effects of treatment with microtubule depolymerizing and stabilizing drugs were described. Results: Among cell lines, up to 30% of cells expressed McTNs. Four McTN morphologies (absent, symmetric-short, symmetric-long, tufted) were observed in immortalized cultures as well as ascites. McTN number/length varied with histology according to metastatic potential. Most OCCC overexpressed class III ß-tubulin. OCCC/OSC cell lines exhibited a trend towards more microtubule-stabilizing post-translational modifications of α-tubulin relative to HOSE. Microtubule depolymerizing drugs decreased the number/length of McTNs, confirming that McTNs are composed of tubulin. Cells that failed to form McTNs demonstrated differential expression of α-tubulin- and actin-regulating proteins relative to cells that form McTNs. Cluster formation is more susceptible to microtubule targeting agents in cells that form McTNs, suggesting a role for McTNs in aggregation. Conclusions: McTNs likely participate in key aspects of ovarian cancer metastasis. McTNs represent a new therapeutic target for this disease that could refine therapies, including intraperitoneal drug delivery.

Keywords